Awarded contract

NHS Framework Agreement for Branded Medicines – Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025

Details

Buyer: NHS England
Supplier(s): 20 suppliers
Abbvie Ltd
Accord UK Ltd
Alexion Pharmaceuticals
Amgen Ltd
Celltrion Healthcare United Kingdom Ltd
CuraTeQ Biologics s.r.o.
Dr Reddy's Laboratories (UK) Ltd
FRESENIUS KABI LIMITED
GLAXOSMITHKLINE UK LIMITED
Janssen Cilag Ltd
Organon Pharmaceuticals UK Ltd
Orifarm UK
Pfizer Liimted
Roche Products Ltd
Samsung Bioepis UK Ltd
Sandoz
Swedish Orphan Biovitrum Ltd (Sobi UK Ltd)
Takeda UK Limited
Thornton and Ross
Zentiva Pharma UK Ltd
Value: £24
Topic: Pharmaceutical products
Published: 29 July 2025
Source: uk:find_a_tender

Tender description

NHS Framework Agreement for Branded Medicines – Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025<br/>CM/PHR/24/5680/01 - Tranche B for North of England and Midlands & East. Period of Framework Agreement: 01 September 2025 to 31 August 2027 <br/>CM/PHR/24/5680/02 - Eculizumab and Ravulizumab for London & SOFE. Period of Framework Agreement: 01 September 2025 to 31 August 2026 Lot 1: Lot 1 - CM/PHR/24/5680/01 - Tranche B for North of England and Midlands & East Tranche B for North of England and Midlands & East. Period of Framework Agreement: 01 September 2025 to 31 August 2027. Additional information: Price is not the only award criterion and all criteria are stated in the procurement documents. Lot 2: Lot 2 - CM/PHR/24/5680/02 - Eculizumab and Ravulizumab for London & SOFE Eculizumab and Ravulizumab for London & SOFE. Additional information: Price is not the only award criterion and all criteria are stated in the procurement documents.

Timeline

Completed: Award date1 July 2025
Completed: Award published29 July 2025
Current notice

About the buyer

NHS England runs the NHS in England, and buys as a central healthcare organisation with its own team of procurement professionals. Every tender is advertised on Atamis, the NHS's single eCommercial system, and larger contracts appear on Find a Tender. Much of this procurement flows through framework agreements and the Crown Commercial Service. Clinical services are commissioned directly or through the Provider Selection Regime. Seven regional teams support the commissioning of healthcare services across the country. The central commercial function that develops procurement strategy for the whole NHS sits here.

UK health spending has nearly quadrupled to £241.8bn in 2024/25, £20bn up on the year before. £140.6bn of that went to procurement, the biggest sector of UK public spending and the fastest-growing.

Over the past 5 years, most of NHS England's contract awards have been in education and training, health and social work, and IT services.

Relevant CPV codes

33600000 · Pharmaceutical products

Decision makers

Connect with the people behind this procurement.

Job title	Phone number	Work email
Head of Procurement	+44 •••• ••••••	••••••••@nhs-england.gov
Commercial Director	+44 •••• ••••••	••••••••@nhs-england.gov
Procurement Manager	+44 •••• ••••••	••••••••@nhs-england.gov
Category Lead	+44 •••• ••••••	••••••••@nhs-england.gov
Senior Buyer	+44 •••• ••••••	••••••••@nhs-england.gov
Contracts Manager	+44 •••• ••••••	••••••••@nhs-england.gov

14 similar open tenders

See more open tenders related to NHS Framework Agreement for Branded Medicines – Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025.

Explore all open tenders